Combined inhibition of BCR-ABL1 and the proteasome as a potential novel therapeutic approach in BCR-ABL positive acute lymphoblastic leukemia
Article in PLOS ONE (October 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in PLOS ONE (October 2022)
Article in Reactions Weekly (September 2017)